PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,908,000 | +28.7% | 605,780 | +18.9% | 0.00% | 0.0% |
| Q2 2020 | $1,483,000 | +3.3% | 509,517 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $1,435,000 | -15.7% | 508,719 | -3.0% | 0.00% | 0.0% |
| Q4 2019 | $1,703,000 | +49.8% | 524,657 | -0.3% | 0.00% | – |
| Q3 2019 | $1,137,000 | -34.5% | 526,304 | -4.8% | 0.00% | -100.0% |
| Q2 2019 | $1,736,000 | +7790.9% | 553,033 | +5247.4% | 0.00% | – |
| Q4 2016 | $22,000 | -38.9% | 10,342 | -2.6% | 0.00% | – |
| Q3 2016 | $36,000 | +9.1% | 10,613 | 0.0% | 0.00% | – |
| Q2 2016 | $33,000 | -10.8% | 10,613 | -4.5% | 0.00% | – |
| Q1 2016 | $37,000 | -9.8% | 11,116 | -4.7% | 0.00% | – |
| Q4 2015 | $41,000 | -34.9% | 11,666 | -6.3% | 0.00% | – |
| Q3 2015 | $63,000 | -21.2% | 12,455 | 0.0% | 0.00% | – |
| Q2 2015 | $80,000 | -9.1% | 12,455 | 0.0% | 0.00% | – |
| Q1 2015 | $88,000 | -50.3% | 12,455 | -45.9% | 0.00% | -100.0% |
| Q4 2014 | $177,000 | +82.5% | 23,001 | +77.6% | 0.00% | 0.0% |
| Q3 2014 | $97,000 | -22.4% | 12,954 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $125,000 | +12.6% | 12,954 | -2.8% | 0.00% | 0.0% |
| Q1 2014 | $111,000 | +13.3% | 13,324 | +14.2% | 0.00% | 0.0% |
| Q4 2013 | $98,000 | +14.0% | 11,666 | +7.8% | 0.00% | 0.0% |
| Q3 2013 | $86,000 | +10.3% | 10,822 | +7.3% | 0.00% | 0.0% |
| Q2 2013 | $78,000 | – | 10,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |